EGFR and non-small cell lung carcinoma: Regarding prognostic factors associated with 1-year PFS and OS in patients with NSCLC; ECOG PS, EGFR mutation, pleural effusion, and EML were associated with 1-year PFS and OS, except for 1-year OS for EML.